Navigation Links
ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients
Date:2/9/2009

- Conference Call at 10:00 A.M. Today to Discuss Results -

EXTON, Pa., Feb. 9 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that its Phase 3 trial evaluating maribavir used as prophylaxis in allogeneic stem cell, or bone marrow, transplant (SCT) patients did not achieve its primary endpoint. In the primary analysis, there was no statistically significant difference between maribavir and placebo in reducing the rate of CMV disease. In addition, the study failed to meet its key secondary endpoints. Maribavir was generally well tolerated in this clinical study.

"We are extremely disappointed by the outcome of this pivotal study," said Vincent J. Milano, ViroPharma's president and chief executive officer. "We just received these data and there are far more questions than answers; we still have a significant amount of work to do to fully understand this outcome and its impact on the overall program. Our disappointment is no doubt shared by physicians and transplant patients, who must today contend with CMV disease."

The primary endpoint of this Phase 3 study was the incidence of CMV disease, confirmed by an independent endpoint committee, within 6 months post-transplant. The incidence of CMV disease within 6 months was 4.4 percent for maribavir compared to 4.8 percent for placebo (P=0.79). The first of four key secondary endpoints was the rate of initiation of anti-CMV treatment within 6 months, which was 37.9 percent for maribavir compared to 40.5 percent for placebo (P=0.49). In addition, the incidence of graft-versus-host disease, mortality and CMV disease-free survival was comparable between the groups.

Conference Call and Webcast

ViroPharma is hosting a live teleconference and webcast with se
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. ViroPharma to Present at the 27th Annual J.P. Morgan Healthcare Conference
2. ViroPharma Provides Update on Vancocin(R)
3. ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema
4. ViroPharma To Present At The 20th Annual Piper Jaffray Healthcare Conference
5. ViroPharma to Discuss Commercialization and Launch of Cinryze(TM) on November 5, 2008
6. ViroPharma Incorporated Reports Third Quarter 2008 Financial Results
7. ViroPharma to Release 2008 Second Quarter Financial Results on July 30, 2008
8. ViroPharma Incorporated Reports First Quarter 2008 Financial Results
9. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2007 Financial Results
10. Vincent J. Milano to Succeed Michel de Rosen as President and Chief Executive Officer of ViroPharma
11. ViroPharma Provides Update on Vancocin(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... March 27, 2015 DrugDev announced company ... Easy was named to the 2015 Philadelphia Business Journal ... list spotlights 40 dynamic, up-and-coming leaders less than 40 ... involvement. Winners are honored at an awards program in ... Philadelphia Business Journal. , Lyn Kremer, Publisher of the ...
(Date:3/27/2015)... UK (PRWEB) March 27, 2015 GenSight, ... it has appointed Sean Fitzgerald, a former technology and ... Operating Officer and Interim Chief Financial Officer. , Mr ... education technology innovator, EverFi, backed by Amazon founder and ... founder Evan Williams. Prior to EverFi, he was a ...
(Date:3/27/2015)... 2015 Operatic contenders and their avid ... April 17th. The universally acclaimed baritone Sherrill Milnes will ... Opera Idol at The Merion in Evanston. The event ... drawn aspiring opera singers from around the country. “This ... the finest young talent in the country,” said Margaret ...
(Date:3/27/2015)... Since September 2014, the country singer has been ... having been in retirement for a period of 13 years. ... return to touring, and concert events have been booking quickly ... sell out for the two shows recently scheduled for May ... the inventory of discounted Garth Brooks tickets for sale. , ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 “ VXi ... of its monthly Tech Report, which features the latest ... a technology expert and special reporter for NewsWatch, conducted ... an advanced noise-cancelling headset, eliminating 90% of ambient noise. ... while texts and emails are important to any professional, ...
Breaking Medicine News(10 mins):Health News:DrugDev Founder Melissa Easy is 2015 Philadelphia Business Journal 40 Under 40 Honoree 2Health News:GenSight Appoints Former Technology Executive as Chief Operating Officer 2Health News:Opera Idol Competition At The Merion In Evanston 2Health News:Garth Brooks Tickets for Omaha: BuyCheapTicketsToEvents.com Draws Customers by Discounting Prices on 2015 Tickets for Garth Brooks’ Tour Stops at CenturyLink Center 2Health News:A Device to Tune out Background Noise was Recently Featured on NewsWatch Television 2
... , TORONTO, July 17 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals ... that its Board of Directors has authorized the Corporation ... pursuant to which the Corporation will offer to purchase ... common shares ("Shares") at a price of Cdn$0.20 (approximately ...
... ... healthcare associations to address high workforce shortage of lab professionals , ... Washington DC (PRWEB) July 17, 2009 ... based in Chicago, today announced it is joining the National Healthcare Career Network (NHCN). ...
... ... , ... July 17, 2009 -- Virtual classmates met face-to-face to celebrate the completion of their ... , ,Graduates gathered in Ophelia Parrish Performing Arts Center on the campus of Truman ...
... on tobacco and alcohol took place in June. The most popular ... 3.30 euros per packet. Are these taxes a form of dissuasion ... harm generated by those who smoke? A study by the Polytechnic ... the tobacco economy. The research, carried out by ...
... , , DALLAS, July 16 ... Baylor University Medical Center at Dallas (Baylor Dallas) in its America,s ... to achieve this distinction. , , ... Joel Allison, president and chief executive officer, Baylor Health Care System. ...
... , , , , ... a new technical assistance fact sheet on legal requirements relating to ... granting state licensure in occupations such as barbering, massage therapy and ... Persons with HIV and AIDS unfortunately still face obstacles ...
Cached Medicine News:Health News:Bradmer to repurchase up to 8.3 million of its common shares pursuant to a substantial issuer bid 2Health News:Bradmer to repurchase up to 8.3 million of its common shares pursuant to a substantial issuer bid 3Health News:Bradmer to repurchase up to 8.3 million of its common shares pursuant to a substantial issuer bid 4Health News:American Society for Clinical Pathology Joins the National Healthcare Career Network 2Health News:American Society for Clinical Pathology Joins the National Healthcare Career Network 3Health News:School of Health Management Honors 162 Graduating Students 2Health News:Is a society with smokers profitable? 2Health News:Is a society with smokers profitable? 3Health News:Baylor Dallas Recognized In U.S. News Media Group's 2009 - 2010 America's Best Hospitals 2Health News:Baylor Dallas Recognized In U.S. News Media Group's 2009 - 2010 America's Best Hospitals 3
(Date:3/27/2015)... March 27, 2015  Valeant Pharmaceuticals International, Inc. (NYSE: ... of its previously announced registered offering of common shares ... "Offering"). Pursuant to the Offering, the Company issued 7,286,432 ... for aggregate gross proceeds of approximately $1.45 billion. On ... Securities and Exchange Commission a final prospectus supplement to ...
(Date:3/27/2015)... NORTH HOLLYWOOD, Calif. , March 27, 2015 /PRNewswire/ ... quality of life of myeloma patients while working toward ... Brian Higgins (D-NY) for introducing a federal resolution ... month of March 2015 as "National Multiple Myeloma Awareness ... people living with myeloma worldwide, and more than 110,000 ...
(Date:3/27/2015)... March 27, 2015  Johnson & Johnson (NYSE: JNJ ... a.m. (Eastern Time) on Thursday, April 23, 2015, from the ... Investors and other interested parties may access the ... website at www.jnj.com and clicking on the webcast ... will be made available a few hours after the live ...
Breaking Medicine Technology:Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3The International Myeloma Foundation (IMF) Secures the Introduction of a Federal Resolution Recognizing March 2015 as "National Multiple Myeloma Awareness Month" 2
... ADD NEW CENTERS AND TO ... INCREASE AWARENESS AMONG CARDIOLOGISTS, PLEASANTON, Calif., April 21 ... device-based mechanical,circulatory support therapies to save, support and restore failing ... PMA (PreMarket,Approval) application, allowing the use of its HeartMate II ...
... EDISON, N.J., April 21 Nostrum, a ... today that it has,successfully completed its early, ... protein currently known as SMRX11. Nostrum,s,Symmetrix subsidiary, ... drug under Nostrum,s license from the Institute ...
Cached Medicine Technology:Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation 2Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation 3Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation 4Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation 5Nostrum Announces the Successful Completion of Early Proof-of-Concept Study for its Novel Clot Busting Therapeutic Protein 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: